(DHI) DR Horton - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US23331A1097

Homes, Land, Mortgages, Title, Rentals

EPS (Earnings per Share)

EPS (Earnings per Share) of DHI over the last years for every Quarter: "2020-09": 2.24, "2020-12": 2.14, "2021-03": 2.53, "2021-06": 3.11, "2021-09": 3.7, "2021-12": 3.17, "2022-03": 4.03, "2022-06": 4.67, "2022-09": 4.67, "2022-12": 2.76, "2023-03": 2.73, "2023-06": 3.9, "2023-09": 4.45, "2023-12": 2.82, "2024-03": 3.52, "2024-06": 4.1, "2024-09": 3.92, "2024-12": 2.61, "2025-03": 2.58, "2025-06": 3.36, "2025-09": 3.04,

Revenue

Revenue of DHI over the last years for every Quarter: 2020-09: 6400.4, 2020-12: 5933.4, 2021-03: 6446.9, 2021-06: 7284.6, 2021-09: 8109.3, 2021-12: 7053.4, 2022-03: 7999, 2022-06: 8788.1, 2022-09: 9639.4, 2022-12: 7257.8, 2023-03: 7972.9, 2023-06: 9725.6, 2023-09: 10504, 2023-12: 7726, 2024-03: 9107.2, 2024-06: 9965.7, 2024-09: 10002.6, 2024-12: 7613, 2025-03: 7734, 2025-06: 9225.6, 2025-09: 9677.8,
Risk via 10d forecast
Volatility 37.4%
Value at Risk 5%th 57.6%
Relative Tail Risk -6.44%
Reward TTM
Sharpe Ratio -0.18
Alpha -17.39
Character TTM
Hurst Exponent 0.268
Beta 0.530
Beta Downside 0.147
Drawdowns 3y
Max DD 41.28%
Mean DD 13.26%
Median DD 9.92%

Description: DHI DR Horton September 26, 2025

D.R. Horton (NYSE:DHI) is the largest U.S. homebuilder, operating in 125 markets across 36 states and covering six geographic regions (East, North, Southeast, South Central, Southwest, Northwest). The firm acquires and develops land, constructs and sells single-family detached homes as well as attached units (townhomes, duplexes, triplexes), and offers ancillary services such as mortgage financing, title insurance, and closing services. It also participates in residential lot development and owns/leases both multifamily and single-family rental properties, plus non-residential assets like ranch land.

Key performance indicators from the most recent FY 2023 filing show revenue of roughly $26.5 billion, net income of $2.9 billion and diluted EPS of $7.68. The company reported a backlog of about $30 billion, indicating strong forward order flow, while the average selling price (ASP) of homes rose to approximately $400 k, driven by a shift toward higher-priced “move-up” buyers. D.R. Horton’s land-bank grew to ~5,200 acres, giving it flexibility to sustain build-out despite recent price volatility.

Primary economic drivers for D.R. Horton include mortgage-rate movements, housing-starts data, and labor-cost pressures. A 1-percentage-point increase in the 30-year fixed rate historically depresses home-buyer demand and can shave 2–3 percentage points off the company’s annual revenue growth rate. Conversely, a tightening of new-home inventory (the “housing shortage” narrative) supports pricing power and can boost ASPs by 2-4 % YoY. Construction-labor shortages and material-cost inflation remain material cost-headwinds, with the U.S. Bureau of Labor Statistics reporting construction-worker wages up ~5 % YoY in Q2 2024.

Sector-level trends such as the “Millennial-first-time-buyer” wave and the ongoing migration toward Sun Belt metros (e.g., Texas, Florida, Arizona) underpin D.R. Horton’s geographic diversification strategy, while the company’s vertical integration of financing and title services helps capture ancillary margin that peers often miss.

For a deeper, data-driven assessment of D.R. Horton’s valuation relative to these fundamentals, you may find the analytical dashboards on ValueRay worth exploring.

DHI Stock Overview

Market Cap in USD 41,001m
Sub-Industry Homebuilding
IPO / Inception 1992-06-05
Return 12m vs S&P 500 -23.1%
Analyst Rating 3.62 of 5

DHI Dividends

Metric Value
Dividend Yield 1.12%
Yield on Cost 5y 2.25%
Yield CAGR 5y 15.72%
Payout Consistency 83.1%
Payout Ratio 14.2%

DHI Growth Ratios

Metric Value
CAGR 3y 22.29%
CAGR/Max DD Calmar Ratio 0.54
CAGR/Mean DD Pain Ratio 1.68
Current Volume 5408k
Average Volume 2694.6k

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (3.59b TTM) > 0 and > 6% of Revenue (6% = 2.06b TTM)
FCFTA 0.09 (>2.0%) and ΔFCFTA 3.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 72.16% (prev 88.88%; Δ -16.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.10 (>3.0%) and CFO 3.42b <= Net Income 3.59b (YES >=105%, WARN >=100%)
Net Debt (1.82b) to EBITDA (4.84b) ratio: 0.38 <= 3.0 (WARN <= 3.5)
Current Ratio 5.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (297.4m) change vs 12m ago -9.14% (target <= -2.0% for YES)
Gross Margin 23.70% (prev 25.91%; Δ -2.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 95.70% (prev 101.9%; Δ -6.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 156.4 (EBITDA TTM 4.84b / Interest Expense TTM 30.3m) >= 6 (WARN >= 3)

Altman Z'' 11.35

(A) 0.70 = (Total Current Assets 30.89b - Total Current Liabilities 6.17b) / Total Assets 35.47b
(B) 0.88 = Retained Earnings (Balance) 31.04b / Total Assets 35.47b
warn (B) unusual magnitude: 0.88 — check mapping/units
(C) 0.13 = EBIT TTM 4.74b / Avg Total Assets 35.79b
(D) 2.89 = Book Value of Equity 31.05b / Total Liabilities 10.73b
Total Rating: 11.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 69.06

1. Piotroski 5.0pt
2. FCF Yield 7.70%
3. FCF Margin 9.63%
4. Debt/Equity 0.19
5. Debt/Ebitda 0.38
6. ROIC - WACC (= 4.51)%
7. RoE 14.71%
8. Rev. Trend 20.59%
9. EPS Trend -9.70%

What is the price of DHI shares?

As of November 24, 2025, the stock is trading at USD 146.71 with a total of 5,408,018 shares traded.
Over the past week, the price has changed by +6.50%, over one month by -7.18%, over three months by -12.90% and over the past year by -14.16%.

Is DHI a buy, sell or hold?

DR Horton has received a consensus analysts rating of 3.62. Therefor, it is recommend to hold DHI.
  • Strong Buy: 6
  • Buy: 3
  • Hold: 10
  • Sell: 2
  • Strong Sell: 0

What are the forecasts/targets for the DHI price?

Issuer Target Up/Down from current
Wallstreet Target Price 162.1 10.5%
Analysts Target Price 162.1 10.5%
ValueRay Target Price 157.8 7.6%

DHI Fundamental Data Overview November 21, 2025

Market Cap USD = 41.00b (41.00b USD * 1.0 USD.USD)
P/E Trailing = 11.8868
P/E Forward = 12.1803
P/S = 1.1971
P/B = 1.6854
P/EG = 1.0667
Beta = 1.386
Revenue TTM = 34.25b USD
EBIT TTM = 4.74b USD
EBITDA TTM = 4.84b USD
Long Term Debt = 7.25b USD (from longTermDebt, two quarters ago)
Short Term Debt = 5.97b USD (from shortTermDebt, last quarter)
Debt = 4.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b USD (from netDebt column, last quarter)
Enterprise Value = 42.82b USD (41.00b + Debt 4.56b - CCE 2.74b)
Interest Coverage Ratio = 156.4 (Ebit TTM 4.74b / Interest Expense TTM 30.3m)
FCF Yield = 7.70% (FCF TTM 3.30b / Enterprise Value 42.82b)
FCF Margin = 9.63% (FCF TTM 3.30b / Revenue TTM 34.25b)
Net Margin = 10.47% (Net Income TTM 3.59b / Revenue TTM 34.25b)
Gross Margin = 23.70% ((Revenue TTM 34.25b - Cost of Revenue TTM 26.13b) / Revenue TTM)
Gross Margin QoQ = 21.67% (prev 23.95%)
Tobins Q-Ratio = 1.21 (Enterprise Value 42.82b / Total Assets 35.47b)
Interest Expense / Debt = 0.66% (Interest Expense 30.3m / Debt 4.56b)
Taxrate = 23.90% (288.0m / 1.20b)
NOPAT = 3.61b (EBIT 4.74b * (1 - 23.90%))
Current Ratio = 5.00 (Total Current Assets 30.89b / Total Current Liabilities 6.17b)
Debt / Equity = 0.19 (Debt 4.56b / totalStockholderEquity, last quarter 24.19b)
Debt / EBITDA = 0.38 (Net Debt 1.82b / EBITDA 4.84b)
Debt / FCF = 0.55 (Net Debt 1.82b / FCF TTM 3.30b)
Total Stockholder Equity = 24.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.11% (Net Income 3.59b / Total Assets 35.47b)
RoE = 14.71% (Net Income TTM 3.59b / Total Stockholder Equity 24.38b)
RoCE = 14.99% (EBIT 4.74b / Capital Employed (Equity 24.38b + L.T.Debt 7.25b))
RoIC = 11.74% (NOPAT 3.61b / Invested Capital 30.73b)
WACC = 7.22% (E(41.00b)/V(45.56b) * Re(7.97%) + D(4.56b)/V(45.56b) * Rd(0.66%) * (1-Tc(0.24)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -5.88%
[DCF Debug] Terminal Value 78.95% ; FCFE base≈2.81b ; Y1≈2.94b ; Y5≈3.42b
Fair Price DCF = 203.7 (DCF Value 59.98b / Shares Outstanding 294.5m; 5y FCF grow 5.06% → 3.0% )
EPS Correlation: -9.70 | EPS CAGR: 3.58% | SUE: -0.85 | # QB: 0
Revenue Correlation: 20.59 | Revenue CAGR: 11.03% | SUE: 0.62 | # QB: 0

Additional Sources for DHI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle